Core Viewpoint - The upcoming IPO review period from November 3 to November 7 will feature five companies aiming to raise a total of 3.812 billion yuan [1]. IPO Companies Overview - Five companies are scheduled for IPO review: - Qilong Ocean (Shandong) aims to raise 381.889 million yuan, with a net profit of 50.67 million yuan [2][5]. - Zhixin Co., Ltd. plans to raise 1.329 billion yuan, reporting a net profit of 203.964 million yuan [2][10]. - Shaanxi Tourism intends to raise 1.555 billion yuan, with a net profit of 621.578 million yuan [2][15]. - Haiseng Medical (Zhejiang) seeks to raise 370.425 million yuan, with a net profit of 70.918 million yuan [2][20]. - Guoliang New Materials (Hebei) aims to raise 175.022 million yuan, reporting a net profit of 70.965 million yuan [2][25]. Fundraising Adjustments - Guoliang New Materials reduced its fundraising target from 301 million yuan to 175 million yuan, eliminating the R&D center project and adjusting working capital needs [3]. Financial Performance - Qilong Ocean reported total assets of 432.166 million yuan and a net profit of 49.075 million yuan for the first half of 2025 [7]. - Zhixin Co., Ltd. had total assets of 427.830 million yuan and a net profit of 9.448 million yuan for the first half of 2025 [12]. - Shaanxi Tourism's total assets reached 214.426 million yuan with a net profit of 24.707 million yuan for the first half of 2025 [17]. - Haiseng Medical reported total assets of 519.449 million yuan and a net profit of 35.494 million yuan for the first half of 2025 [23]. - Guoliang New Materials had total assets of 1.520 billion yuan and a net profit of 41.497 million yuan for the first half of 2025 [26]. Investment Projects - Qilong Ocean's main investment project is the high-performance large-diameter riser pipe production project, with a total investment of 381.889 million yuan [9]. - Zhixin Co., Ltd. plans to expand its production capacity and technology for automotive welding components, with a total investment of 1.329 billion yuan [13]. - Shaanxi Tourism's investment projects include the construction of various tourism facilities, totaling 1.555 billion yuan [19]. - Haiseng Medical's investment projects focus on upgrading and expanding production capabilities for anesthesia and monitoring medical devices, with a total investment of 482.701 million yuan [24]. - Guoliang New Materials is involved in high-temperature industrial refractory materials, with a total investment of 175.022 million yuan for its projects [27].

浙江荣泰电工器材股份有限公司 首次公开发行股票并在主板上市 发行公告 保荐人（主承销商）：东兴证券股份有限公司 重要提示 浙江荣泰电工器材股份有限公司（以下简称"浙江荣泰"、"发行人"或"公司"） 根据中国证券监督管理委员会（以下简称"中国证监会"、"证监会"）颁布的《证 券发行与承销管理办法》（证监会令〔第 208 号〕）（以下简称"《管理办法》"）、 《首次公开发行股票注册管理办法》（证监会令〔第 205 号〕），上海证券交易所 （以下简称"上交所"）颁布的《上海证券交易所首次公开发行证券发行与承销业 务实施细则》（上证发〔2023〕33 号）（以下简称"《首发承销实施细则》"）、《上 海市场首次公开发行股票网上发行实施细则（2023 年修订）》（上证发〔2023〕35 号）（以下简称"《网上发行实施细则》"）、《上海市场首次公开发行股票网下发行 实施细则（2023 年修订）》（上证发〔2023〕36 号）（以下简称"《网下发行实施 细则》"），中国证券业协会颁布的《首次公开发行证券承销业务规则》（中证协 发〔2023〕18 号）以及《首次公开发行证券网下投资者管理规则》和《首次公开 发行证券网下投资者分 ...

浙江荣泰电工器材股份有限公司 首次公开发行股票并在主板上市 招股意向书提示性公告 浙江荣泰电工器材股份有限公司（以下简称"浙江荣泰"、"发行人"或"公司"） 首次公开发行股票并在主板上市的申请已经上海证券交易所（以下简称"上交所"） 上市审核委员会审议通过，并已经中国证券监督管理委员会（以下简称"中国证 监会"）证监许可〔2023〕1288 号文同意注册。《浙江荣泰电工器材股份有限公 司首次公开发行股票并在主板上市招股意向书》及附录在上海证券交易所网站 （http://www.sse.com.cn/）和符合中国证监会规定条件网站（中证网，网址： www.cs.com.cn；中国证券网，网址：www.cnstock.com；证券时报网，网址： www.stcn.com；证券日报网，网址：www.zqrb.cn）披露，并置备于发行人、上 交所、本次发行保荐人（主承销商）东兴证券股份有限公司的住所，供公众查阅。 敬请投资者重点关注本次发行流程、网上网下申购及缴款、弃购股份处理等 方面，并认真阅读同日披露于上海证券交易所网站和符合中国证监会规定条件网 站上的《浙江荣泰电工器材股份有限公司首次公开发行股票并在主板上市发 ...